1.8.98.2	A-549 cell	-	659421, 698052, 698928, 698993, 700520, 725510	
1.8.98.2	A-549 cell	derived from adenocarcinoma	765061	
1.8.98.2	adrenal gland	-	742566, 743228	
1.8.98.2	BEAS-2B cell	-	698052	
1.8.98.2	brown adipose tissue	-	742566	
1.8.98.2	carcinoma cell	-	765246	
1.8.98.2	cardiomyocyte	-	742457	
1.8.98.2	embryonic fibroblast	-	725510	
1.8.98.2	glial cell	cortical glial cell, in both neurons and glia, Nrf2 expression and treatment with chemopreventive Nrf2 activators, including 3H-1,2-dithiole-3-thione and sulforaphane, upregulate sulfiredoxin, an enzyme responsible for reducing hyperoxidized peroxiredoxins	688522	
1.8.98.2	H9c2 cell	-	742457	
1.8.98.2	heart	-	742457, 742566	
1.8.98.2	HEK-293 cell	-	698993, 700520	
1.8.98.2	HEK-293T cell	-	765061	
1.8.98.2	HeLa cell	-	659421, 698928, 698993	
1.8.98.2	kidney	-	659421	
1.8.98.2	leaf	-	-, 668202, 712607, 764076	
1.8.98.2	lung	-	659421, 698052	
1.8.98.2	lung cancer cell	Srx is highly expressed in primary specimen of lung cancer patients	765061	
1.8.98.2	MCF-7 cell	-	700520	
1.8.98.2	NCI-H226 cell	derived from squamous cell carcinoma	765061	
1.8.98.2	neuron	cortical neuron, in both neurons and glia, Nrf2 expression and treatment with chemopreventive Nrf2 activators, including 3H-1,2-dithiole-3-thione and sulforaphane, upregulate sulfiredoxin, an enzyme responsible for reducing hyperoxidized peroxiredoxins	688522	
1.8.98.2	PC-12 cell	-	743135	
1.8.98.2	spleen	-	659421	
1.8.98.2	thymus	-	659421